MD Pediatrix Medical Group
Pediatrix Medical Group earnings company data as of 6:45 AM ET 10/21
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 2 Nov | EPS | 0.59 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by MD's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $1.8M sold by 4 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Shirley A Weis DirectorSale$856K 36,028 shares at $23.75 100% of stakeTraded May 13 Filed May 14
-
Mark S Ordan CEOSale$515K 23,000 shares at $22.41 7.1% of stakeTraded Dec 15, 2025 Filed Dec 17, 2025
-
Michael A. Rucker DirectorSale$241K 10,478 shares at $23.00 15% of stakeTraded Nov 17, 2025 Filed Nov 19, 2025
-
Laura A Linynsky DirectorSale$217K 10,000 shares at $21.65 24% of stakeTraded Nov 6, 2025 Filed Nov 10, 2025
Also filed in the last 12 months, not counted as buying or selling: 22 stock grants, 6 share withholdings for taxes, 5 gifts, and 3 sales back to the company.
SEC filings
Recent issuer filings from EDGAR, 13 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.02,7.01 | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 5.02,5.07,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| DEFA14A | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.